New 52 Week High Today

Novavax Inc NVAX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:31 PM EDT
16.23quote price arrow up+1.32 (+8.85%)
Volume
20,496,225
52 week range
3.53 - 17.40
Loading...
  • Open14.88
  • Day High17.40
  • Day Low14.80
  • Prev Close14.91
  • 52 Week High17.40
  • 52 Week High Date05/22/24
  • 52 Week Low3.53
  • 52 Week Low Date02/05/24

Key Stats

  • Market Cap2.279B
  • Shares Out140.42M
  • 10 Day Average Volume45.51M
  • Dividend-
  • Dividend Yield-
  • Beta2.02
  • YTD % Change243.58

KEY STATS

  • Open14.88
  • Day High17.40
  • Day Low14.80
  • Prev Close14.91
  • 52 Week High17.40
  • 52 Week High Date05/22/24
  • 52 Week Low3.53
  • 52 Week Low Date02/05/24
  • Market Cap2.279B
  • Shares Out140.42M
  • 10 Day Average Volume45.51M
  • Dividend-
  • Dividend Yield-
  • Beta2.02
  • YTD % Change243.58

RATIOS/PROFITABILITY

  • EPS (TTM)-3.18
  • P/E (TTM)-5.11
  • Fwd P/E (NTM)-64.66
  • EBITDA (TTM)-339.945M
  • ROE (TTM)-898.20%
  • Revenue (TTM)996.609M
  • Gross Margin (TTM)63.04%
  • Net Margin (TTM)-40.01%
  • Debt To Equity (MRQ)-26.45%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype...
James Young Ph.D.
Independent Chairman of the Board
John Jacobs
President, Chief Executive Officer, Director
John Trizzino
President, Chief Operating Officer
James Kelly
Chief Financial Officer, Executive Vice President, Treasurer
John Herrmann III
Executive Vice President
Address
700 Quince Orchard Road
Gaithersburg, MD
20878
United States

Top Peers

SYMBOLLASTCHG%CHG
PTCT
PTC Therapeutics Inc
38.61-0.24-0.62%
ACAD
ACADIA Pharmaceuticals Inc
15.79+0.52+3.37%
MYGN
Myriad Genetics Inc
24.77+0.39+1.62%
GLPG
Galapagos NV
28.31-0.07-0.25%
NVCR
Novocure Ltd
23.55+0.80+3.52%